Empowered Funds’s BridgeBio Pharma BBIO Stock Holding History

Empowered Funds’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-34,623	Closed	-$1.62M	–	248
2021 Q3	$1.62M	Buy	+34,623	New	+$1.86M	0.21%	115

Other funds holding BBIO

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Empowered Funds's BBIO Position: Q4 2021 in Review

Empowered Funds sold out of BridgeBio Pharma (BBIO) in Q4 2021, closing a stake of 34,623 shares — an estimated $1.62M sold.

Empowered Funds first reported a position in BBIO in Q3 2021 and held it in 1 quarter. The position peaked at $1.62M in Q3 2021. 195 funds tracked by Wall St. Rank hold BBIO as of Q4 2021.

Empowered Funds reported no remaining BridgeBio Pharma position as of Q4 2021 after selling out during the quarter.
Empowered Funds sold 34,623 BridgeBio Pharma shares in Q4 2021, an estimated $1.62M.
Empowered Funds first reported a position in BridgeBio Pharma in Q3 2021 and held it in 1 quarter.
Empowered Funds's BridgeBio Pharma position peaked at $1.62M in Q3 2021.
195 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q4 2021.

Based on Empowered Funds's 13F filing for Q4 2021, filed 10 Feb 2022.